Early growth response genes regulate B cell development, proliferation, and immune response

被引:55
作者
Gururajan, Murali [1 ,2 ,3 ]
Simmons, Alan [1 ,2 ]
Dasu, Trivikram [1 ,2 ]
Spear, Brett T. [1 ,3 ,4 ]
Calulot, Christopher [1 ]
Robertson, Darrell A. [1 ,2 ]
Wiest, David L. [5 ]
Monroe, John G. [6 ]
Bondada, Subbarao [1 ,2 ,3 ,4 ]
机构
[1] Univ Kentucky, Dept Microbiol Immunol, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Mol Genet, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[3] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA
[4] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA
[5] Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA
[6] Hosp Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
D O I
10.4049/jimmunol.181.7.4590
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Egr-1 (early growth response gene-1) is an immediate early gene encoding a zinc finger motif-containing transcription factor. Upon cross-linking of BCR, mature B cells undergo proliferation with an increase in Egr-1 message. Immature B lymphoma cells that express Egr-1 message and protein constitutively are growth inhibited when Egr-1 is down-regulated by negative signals from BCR or by antisense oligonucleotides. To test the hypothesis that Egr-1 is important for B cell development, we examined B cells from primary and secondary lymphoid organs in Egr-l(-/-) mice. Marginal zone 13 cell development was arrested in these mice, whereas the B cells in all other compartments were increased. To test the hypothesis that Egr-1 function may be partially compensated by other Ear family members, we developed transgenic mice expressing a dominant negative form of Egr-1, which lacks the trans activation domain but retains the DNA-binding domain, in a B cell-specific manner. There was a decrease in B lymphopoiesis in the bone marrow accompanied by a reduction in splenic immature and mature B cells as well as marginal zone B cells in the transgenic mice. Moreover, transgenic mice respond poorly to BCR cross-linking in vitro and T-independent and T-dependent Ags in vivo.
引用
收藏
页码:4590 / 4602
页数:13
相关论文
共 59 条
  • [1] Impaired prostate tumorigenesis in Egr1-deficient mice
    Abdulkadir, SA
    Qu, ZC
    Garabedian, E
    Song, SK
    Peters, TJ
    Svaren, J
    Carbone, JM
    Naughton, CK
    Catalona, WJ
    Ackerman, JJH
    Gordon, JI
    Humphrey, PA
    Milbrandt, J
    [J]. NATURE MEDICINE, 2001, 7 (01) : 101 - 107
  • [2] Adamson E, 2003, CANCER BIOL THER, V2, P617
  • [3] Egr1 transcription factor: Multiple roles in prostate tumor cell growth and survival
    Adamson, ED
    Mercola, D
    [J]. TUMOR BIOLOGY, 2002, 23 (02) : 93 - 102
  • [4] Peripheral B cell subsets
    Allman, David
    Pillai, Shiv
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (02) : 149 - 157
  • [5] Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2
  • [6] Thymocyte development in early growth response gene 1-deficient mice
    Bettini, M
    Xi, HK
    Milbrandt, J
    Kersh, GJ
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (04) : 1713 - 1720
  • [7] IDENTIFICATION AND CHARACTERIZATION OF THE EGR-1 GENE-PRODUCT, A DNA-BINDING ZINC FINGER PROTEIN-INDUCED BY DIFFERENTIATION AND GROWTH SIGNALS
    CAO, XM
    KOSKI, RA
    GASHLER, A
    MCKIERNAN, M
    MORRIS, CF
    GAFFNEY, R
    HAY, RV
    SUKHATME, VP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (05) : 1931 - 1939
  • [8] Early growth response transcription factors are required for development of CD4-CD8- thymocytes to the CD4+CD8+ stage
    Carleton, M
    Haks, MC
    Smeele, SAA
    Jones, A
    Belkowski, SM
    Berger, MA
    Linsley, P
    Kruisbeek, AM
    Wiest, DL
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (04) : 1649 - 1658
  • [9] THE EGR1 PROTEIN CONTAINS A DISCRETE TRANSCRIPTIONAL REGULATORY DOMAIN WHOSE DELETION RESULTS IN A TRUNCATED PROTEIN THAT BLOCKS EGR1-INDUCED TRANSCRIPTION
    CARMAN, JA
    MONROE, JG
    [J]. DNA AND CELL BIOLOGY, 1995, 14 (07) : 581 - 589
  • [10] B cell receptor signal strength determines B cell fate
    Casola, S
    Otipoby, KL
    Alimzhanov, M
    Humme, S
    Uyttersprot, N
    Kutok, JL
    Carroll, MC
    Rajewsky, K
    [J]. NATURE IMMUNOLOGY, 2004, 5 (03) : 317 - 327